Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy.
Zhang J, Sun R, Lyu Y, Liu C, Liu Y, Feng Y, Fu M, Wong PJC, Du Z, Qiu T, Zhang Y, Zhuang D, Qin Z, Yao Y, Zhu W, Guo T, Hua W, Yang H, Mao Y.
Zhang J, et al. Among authors: lyu y.
Nat Commun. 2024 Nov 19;15(1):10005. doi: 10.1038/s41467-024-54352-5.
Nat Commun. 2024.
PMID: 39562821
Free PMC article.